Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortMonthly antibody injection to prevent migraine.Migraine melt that treats and prevents attacks.
Body systemBrain & NervesBrain & Nerves
Drug classCGRP antibodiesGepants
SupplyPrescription onlyPrescription only
Main usesMigraine preventionMigraine attacks, Migraine prevention
How it worksBlocks a pain-signalling protein involved in migraine.Blocks a migraine-triggering chemical without tightening blood vessels.
Starts workingWeeks to months—
Half-lifeAbout 28 daysAbout 11 hours
Typical adult dose70 mg once a month; 140 mg once a month if needed.75 mg once a day as needed (treatment) or every other day (prevention).
FormsMonthly pen injectionOrodispersible tablet
Common side effectsInjection site reactions, Constipation, Cramps, ItchingNausea, Indigestion
Serious side effectsSevere constipation, High blood pressure, Allergic reactionsAllergic reactions (rare)
Don't take ifSevere constipation; Allergy to erenumab—
AlcoholBest to limit. Alcohol can trigger migraines.—
PregnancyUsually avoidedLimited data; avoid.Use with cautionLimited data.
BreastfeedingUse with cautionLarge proteins; limited data.—
In use since—2020
Brand namesUnited States: AimovigUnited Kingdom: AimovigIndia: AimovigUnited States: Nurtec ODTUnited Kingdom: VyduraEurope: Vydura
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeN02CD01—

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker